Mair Therapeutics
Mair Therapeutics is a biotechnology startup focused on developing treatments for neurodegenerative disorders, specifically Parkinson's disease. The company is built on a platform that utilizes ion channel modulation and aims to discover compounds that regulate the lysosomal ion channel TMEM175 to address the hallmarks of Parkinson's disease.
Funding Round: Pre-Seed
Funding Amount:
Date: 13-Feb-2025
Investors: Torrey Pines Investment, Oost NL
Markets: Biotechnology, Therapeutics, Neurodegenerative Disorders
HQ: Nijmegen, Netherlands
Founded: 2024
Website: https://mairtx.com/
LinkedIn: https://www.linkedin.com/company/mair-therapeutics
Crunchbase: https://www.crunchbase.com/organization/mair-therapeutics
Leave a Comment
Comments
No comments yet.